학술논문
Real-World Comparative Effectiveness of First-Line Alectinib Versus Crizotinib in Patients With Advanced ALK-Positive NSCLC With or Without Baseline Central Nervous System Metastases
Document Type
Article
Author
Source
In JTO Clinical and Research Reports April 2023 4(4)
Subject
Language
ISSN
2666-3643